Alexion Pharmaceuticals Profit Margin 2006-2018 | ALXN

Current and historical gross margin, operating margin and net profit margin for Alexion Pharmaceuticals (ALXN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Alexion Pharmaceuticals net profit margin as of June 30, 2018 is -2.68%.
Alexion Pharmaceuticals Annual Profit Margin Summary
Alexion Pharmaceuticals Quarterly Profit Margin Summary
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $26.255B $3.551B
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D).
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $129.979B 14.92
Gilead Sciences (GILD) United States $94.348B 10.47
Biogen (BIIB) United States $67.362B 14.28
Celgene (CELG) United States $61.333B 12.25
Illumina (ILMN) United States $51.041B 63.94
Vertex Pharmaceuticals (VRTX) United States $44.927B 102.21
Regeneron Pharmaceuticals (REGN) United States $41.762B 23.48
BioMarin Pharmaceutical (BMRN) United States $17.431B 0.00
Incyte (INCY) United States $14.247B 478.71
Seattle Genetics (SGEN) United States $12.094B 0.00
Sarepta Therapeutics (SRPT) United States $10.123B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.397B 0.00
Exact Sciences (EXAS) United States $9.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.881B 57.03
BeiGene (BGNE) Cayman Islands $8.602B 0.00
QIAGEN (QGEN) Netherlands $8.541B 27.92
Bio-Techne Corp (TECH) United States $7.433B 49.71
Bluebird Bio (BLUE) United States $7.430B 0.00
Alkermes (ALKS) Ireland $5.995B 0.00
Galapagos (GLPG) Belgium $5.924B 0.00
Ligand Pharmaceuticals (LGND) United States $5.353B 47.42
Exelixis (EXEL) United States $4.730B 15.41
Immunomedics (IMMU) United States $4.211B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.139B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.511B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.492B 0.00
Myriad Genetics (MYGN) United States $3.287B 36.79
Emergent Biosolutions (EBS) United States $3.246B 25.85
Horizon Pharma Public (HZNP) Ireland $3.203B 18.13
ARGENX SE-ADR (ARGX) Netherlands $3.017B 0.00
Blueprint Medicines (BPMC) United States $3.014B 0.00
Array BioPharma (ARRY) United States $2.923B 0.00
Ascendis Pharma (ASND) Denmark $2.831B 0.00
China Biologic Products (CBPO) China $2.728B 18.01
Reata Pharmaceuticals (RETA) United States $2.724B 0.00
Repligen (RGEN) United States $2.510B 84.25
Medicines (MDCO) United States $2.476B 0.00
Halozyme Therapeutics (HALO) United States $2.407B 32.08
MyoKardia (MYOK) United States $2.397B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.395B 0.00
Acceleron Pharma (XLRN) United States $2.389B 0.00
Genomic Health (GHDX) United States $2.329B 129.92
REGENXBIO (RGNX) United States $2.273B 35.71
G1 THERAPEUTICS (GTHX) United States $2.218B 0.00
Amicus Therapeutics (FOLD) United States $2.217B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.150B 0.00
Spark Therapeutics (ONCE) United States $2.146B 0.00
Global Blood Therapeutics (GBT) United States $2.145B 0.00
Akcea Therapeutics (AKCA) United States $2.130B 0.00
AnaptysBio (ANAB) United States $2.124B 0.00
Cambrex (CBM) United States $2.085B 16.72
Arena Pharmaceuticals (ARNA) United States $2.052B 0.00
Allakos (ALLK) United States $1.853B 0.00
Denali Therapeutics (DNLI) United States $1.776B 0.00
Atara Biotherapeutics (ATRA) United States $1.773B 0.00
Mirati Therapeutics (MRTX) United States $1.770B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.756B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.709B 0.00
Rubius Therapeutics (RUBY) United States $1.708B 0.00
Clovis Oncology (CLVS) United States $1.697B 0.00
Puma Biotechnology (PBYI) United States $1.677B 0.00
Aimmune Therapeutics (AIMT) United States $1.643B 0.00
Myovant Sciences (MYOV) United Kingdom $1.616B 0.00
Solid Biosciences (SLDB) United States $1.586B 0.00
Editas Medicine (EDIT) United States $1.519B 0.00
Innoviva (INVA) United States $1.504B 9.65
Sangamo Therapeutics (SGMO) United States $1.495B 0.00
Insmed (INSM) United States $1.460B 0.00
Audentes Therapeutics (BOLD) United States $1.455B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.439B 0.00
WAVE Life Sciences (WVE) Singapore $1.434B 0.00
UniQure (QURE) Netherlands $1.430B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.384B 0.00
DBV Technologies (DBVT) France $1.370B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.308B 0.00
IMMURON LTD (IMRN) Australia $1.302B 0.00
Intellia Therapeutics (NTLA) United States $1.290B 0.00
Lion Biotechnologies (IOVA) United States $1.252B 0.00
Cellectis (CLLS) France $1.172B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.163B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.157B 0.00
Coherus BioSciences (CHRS) United States $1.153B 0.00
Retrophin (RTRX) United States $1.147B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.146B 0.00
NeoGenomics (NEO) United States $1.134B 198.43
Intra-Cellular Therapies (ITCI) United States $1.122B 0.00
Athenex (ATNX) United States $1.092B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.080B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.056B 0.00
Apellis Pharmaceuticals (APLS) United States $1.044B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.041B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.011B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.000B 1910.00
Geron (GERN) United States $0.993B 0.00
AVROBIO (AVRO) United States $0.989B 0.00
UNITY Biotechnology (UBX) $0.972B 0.00
Aptinyx (APTX) United States $0.942B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.883B 0.00
Revance Therapeutics (RVNC) United States $0.870B 0.00
Cara Therapeutics (CARA) United States $0.833B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.833B 0.00
CytomX Therapeutics (CTMX) United States $0.832B 0.00
Amarin (AMRN) Ireland $0.827B 0.00
Acorda Therapeutics (ACOR) United States $0.826B 17.23
Heska (HSKA) United States $0.818B 70.37
InflaRx (IFRX) Germany $0.769B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.761B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.746B 0.00
Dynavax Technologies (DVAX) United States $0.742B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.732B 0.00
Epizyme (EPZM) United States $0.699B 0.00
Abeona Therapeutics (ABEO) United States $0.671B 0.00
Scholar Rock Holding (SRRK) United States $0.638B 0.00
Kura Oncology (KURA) United States $0.632B 0.00
Viking Therapeutics (VKTX) United States $0.630B 0.00
ANI Pharmaceuticals (ANIP) United States $0.627B 12.41
UROGEN PHARMA (URGN) Israel $0.619B 0.00
Verastem (VSTM) United States $0.606B 0.00
ObsEva SA (OBSV) Switzerland $0.601B 0.00
Anika Therapeutics (ANIK) United States $0.598B 25.14
Fate Therapeutics (FATE) United States $0.591B 0.00
BeyondSpring (BYSI) United States $0.584B 0.00
Replimune (REPL) United States $0.582B 0.00
Mesoblast (MESO) Australia $0.575B 0.00
Arcus Biosciences (RCUS) United States $0.575B 0.00
MiMedx (MDXG) United States $0.561B 24.05
Vericel (VCEL) United States $0.555B 0.00
GTx (GTXI) United States $0.532B 0.00
Stemline Therapeutics (STML) United States $0.528B 0.00
Novavax (NVAX) United States $0.528B 0.00
AC Immune SA (ACIU) Switzerland $0.527B 0.00
Zealand Pharma (ZEAL) Denmark $0.519B 0.00
Arbutus Biopharma (ABUS) Canada $0.515B 0.00
Prothena (PRTA) Ireland $0.506B 0.00
Senesco Technologies (ELOX) United States $0.494B 0.00
Sorrento Therapeutics (SRNE) United States $0.493B 84.50
Aduro Biotech (ADRO) United States $0.490B 0.00
Five Prime Therapeutics (FPRX) United States $0.482B 0.00
MediciNova (MNOV) United States $0.476B 0.00
Eidos Therapeutics (EIDX) United States $0.466B 0.00
Zymeworks (ZYME) Canada $0.459B 0.00
Kindred Biosciences (KIN) United States $0.451B 0.00
Merus (MRUS) Netherlands $0.449B 0.00
Cytokineticsorporated (CYTK) United States $0.448B 0.00
Inovio Pharmaceuticals (INO) United States $0.441B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.438B 0.00
Sinovac Biotech (SVA) China $0.431B 0.00
Syros Pharmaceuticals (SYRS) United States $0.427B 0.00
RA PHARMCTL INC (RARX) United States $0.425B 0.00
Evelo Biosciences (EVLO) United States $0.419B 0.00
Osiris Therapeutics (OSIR) United States $0.409B 0.00
ResTORbio (TORC) United States $0.391B 0.00
Magenta Therapeutics (MGTA) United States $0.389B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.386B 0.00
Albireo Pharma (ALBO) United States $0.384B 0.00
Kadmon Holdings (KDMN) United States $0.380B 0.00
Kezar Life Sciences (KZR) United States $0.379B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.374B 0.00
Adverum Biotechnologies (ADVM) United States $0.370B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.359B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.343B 0.00
Cellular Biomedicine (CBMG) United States $0.335B 0.00
PDL BioPharma (PDLI) United States $0.332B 4.65
Sienna Biopharmaceuticals (SNNA) United States $0.331B 0.00
Synlogic (SYBX) United States $0.331B 0.00
Unum Therapeutics (UMRX) United States $0.331B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.317B 0.00
Selecta Biosciences (SELB) United States $0.317B 0.00
MeiraGTx Holdings (MGTX) United States $0.311B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.306B 0.00
Seres Therapeutics (MCRB) United States $0.304B 0.00
ADMA Biologics Inc (ADMA) United States $0.299B 0.00
Liquidia Technologies (LQDA) United States $0.299B 0.00
Celcuity (CELC) United States $0.297B 0.00
BioTime (BTX) United States $0.293B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.287B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.282B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.275B 0.00
Celyad SA (CYAD) Belgium $0.271B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.265B 0.00
Kala Pharmaceuticals (KALA) United States $0.263B 0.00
MannKind (MNKD) United States $0.262B 0.00
Athersys (ATHX) United States $0.261B 0.00
Mersana Therapeutics (MRSN) United States $0.258B 0.00
Menlo Therapeutics (MNLO) United States $0.244B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.242B 0.00
Kamada (KMDA) Israel $0.238B 18.44
Axovant Sciences (AXON) United Kingdom $0.236B 0.00
NantKwest (NK) United States $0.230B 0.00
Idera Pharmaceuticals (IDRA) United States $0.223B 0.00
Enzo Biochem (ENZ) United States $0.220B 0.00
TOCAGEN INC (TOCA) United States $0.219B 0.00
Allena Pharmaceuticals (ALNA) United States $0.216B 0.00
Palatin Technologies (PTN) United States $0.212B 8.75
Agenus (AGEN) United States $0.207B 0.00
ChromaDex (CDXC) United States $0.207B 0.00
Protagonist Therapeutics (PTGX) United States $0.205B 0.00
Clearside Biomedical (CLSD) United States $0.203B 0.00
Constellation Pharmaceuticals (CNST) United States $0.197B 0.00
Compugen (CGEN) Israel $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.192B 0.00
Cohbar (CWBR) United States $0.187B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.186B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.184B 0.00
Cue Biopharma (CUE) United States $0.183B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Signal Genetics (MGEN) United States $0.177B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.171B 0.00
Mustang Bio (MBIO) United States $0.167B 0.00
BioDelivery Sciences (BDSI) United States $0.167B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.167B 0.00
Krystal Biotech (KRYS) United States $0.163B 0.00
Eleven Biotherapeutics (SESN) United States $0.162B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.161B 0.00
Monster Digital (INNT) United States $0.159B 0.00
Cerecor (CERC) United States $0.159B 19.00
Spring Bank Pharmaceuticals (SBPH) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
Pluristem Therapeutics (PSTI) Israel $0.147B 0.00
OVID THERAPEUTC (OVID) United States $0.145B 0.00
Pfenex (PFNX) United States $0.143B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.143B 0.00
Provention Bio (PRVB) United States $0.140B 0.00
Checkpoint Therapeutics (CKPT) United States $0.139B 0.00
Organovo Holdings (ONVO) United States $0.135B 0.00
XOMA (XOMA) United States $0.131B 13.87
Tapimmune (TPIV) United States $0.131B 0.00
BioXcel Therapeutics (BTAI) United States $0.127B 0.00
PSivida (EYPT) United States $0.126B 0.00
Intec Pharma (NTEC) Israel $0.125B 0.00
Motif Bio Plc (MTFB) United States $0.124B 0.00
Trevena (TRVN) United States $0.123B 0.00
Cidara Therapeutics (CDTX) United States $0.119B 0.00
VBI Vaccines (VBIV) United States $0.117B 0.00
Catalyst Biosciences (CBIO) United States $0.112B 0.00
Aptevo Therapeutics (APVO) United States $0.110B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.107B 0.00
Cel-Sci (CVM) United States $0.106B 0.00
XBiotech (XBIT) United States $0.105B 0.00
Anavex Life Sciences (AVXL) United States $0.101B 0.00
Vaccinex (VCNX) United States $0.101B 0.00
ARIDIS PHARMACT (ARDS) United States $0.100B 0.00
Alcobra (ARCT) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.097B 0.00
Neothetics (EVFM) United States $0.097B 0.00
ScPharmaceuticals (SCPH) United States $0.096B 0.00
Aptose Biosciences (APTO) Canada $0.092B 0.00
NewLink Genetics (NLNK) United States $0.088B 0.00
Fortress Biotech (FBIO) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.087B 0.00
Ophthotech (OPHT) United States $0.085B 0.55
Cocrystal Pharma (COCP) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.083B 0.00
Proteostasis Therapeutics (PTI) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Evogene (EVGN) Israel $0.079B 0.00
Sophiris Bio (SPHS) United States $0.078B 0.00
Alimera Sciences (ALIM) United States $0.078B 0.00
VolitionRX (VNRX) Singapore $0.077B 0.00
Protalix BioTherapeutics (PLX) Israel $0.076B 0.00
Applied Genetic Technologies (AGTC) United States $0.075B 0.00
Asterias Biotherapeutics (AST) United States $0.075B 0.00
Novelion Therapeutics (NVLN) Canada $0.074B 0.00
Oncolytics Biotech (ONCY) Canada $0.074B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.074B 0.00
OncoSec Medical (ONCS) United States $0.072B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.069B 0.00
Chiasma (CHMA) United States $0.068B 0.00
Bellerophon Therapeutics (BLPH) United States $0.068B 0.00
TRACON Pharmaceuticals (TCON) United States $0.066B 0.00
Oncobiologics (ONS) United States $0.062B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
VIVUS (VVUS) United States $0.056B 0.00
CorMedix Inc (CRMD) United States $0.055B 0.00
Curis (CRIS) United States $0.055B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.055B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.054B 0.00
Caladrius Biosciences (CLBS) United States $0.054B 0.00
Celsion (CLSN) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.047B 0.00
Eyenovia (EYEN) United States $0.045B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
AZURRX BIOPHARM (AZRX) United States $0.043B 0.00
Advaxis (ADXS) United States $0.042B 0.00
Aileron Therapeutics (ALRN) United States $0.041B 0.00
BioPharmX (BPMX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
Proteon Therapeutics (PRTO) United States $0.037B 0.00
GENPREX INC (GNPX) United States $0.037B 0.00
CytRx (CYTR) United States $0.035B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
AquaBounty Technologies (AQB) United States $0.034B 0.00
Gemphire Therapeutics (GEMP) United States $0.031B 0.00
Vical (VICL) United States $0.030B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 54.67
Benitec Biopharma (BNTC) Australia $0.026B 0.00
OvaScience (OVAS) United States $0.026B 0.00
Arsanis (ASNS) United States $0.025B 0.00
Soligenix (SNGX) United States $0.024B 0.00
VTv Therapeutics (VTVT) United States $0.024B 0.00
RestorGenex (DFFN) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
Edge Therapeutics (EDGE) United States $0.024B 0.00
ATyr Pharma (LIFE) United States $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.021B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Neuralstem (CUR) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
AmpliPhi Biosciences (APHB) United States $0.016B 0.00
Histogenics (HSGX) United States $0.016B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 4.87
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
Vital Therapies (VTL) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.010B 0.00
IBio (IBIO) United States $0.010B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Aytu Bioscience (AYTU) United States $0.005B 0.00
Oragenics (OGEN) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00